Otros idiomas ANI Pharmaceuticals, Inc.

Acciones

ANIP

US00182C1036

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
65,36 ^USD	+0,63 %		-0,18 %	+18,53 %

17/04	Un iniciado de Ani Pharmaceuticals vendió acciones por valor de 1.500.589 dólares, según un reciente registro de la SEC	MT
09/04	ANI Pharmaceuticals, Inc. anuncia el lanzamiento de la suspensión oral de baclofeno	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET	18/04
Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing	17/04
ANI Pharmaceuticals : Corporate Presentation - April 2024	17/04
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension	09/04
ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension	09/04
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis	04/04
Ani Pharmaceuticals Insider Sold Shares Worth $1,345,000, According to a Recent SEC Filing	03/04
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium	03/04
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP	27/03
ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP	27/03
ANI Pharmaceuticals : Corporate Presentation - March 2024	12/03
Ani Pharmaceuticals Insider Sold Shares Worth $671,700, According to a Recent SEC Filing	12/03
Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing	08/03
Ani Pharmaceuticals Insider Sold Shares Worth $456,400, According to a Recent SEC Filing	06/03
Ani Pharmaceuticals Insider Sold Shares Worth $330,000, According to a Recent SEC Filing	06/03
Sector Update: Health Care Stocks Decline Late Afternoon	29/02
Sector Update: Health Care Stocks Retreat Thursday Afternoon	29/02
ANI Pharmaceuticals Shares Rise After Q4 Adjusted Earnings, Net Revenue Beat Forecasts	29/02
ANI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
ANI: Q4 Earnings Snapshot	29/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas ANI Pharmaceuticals, Inc.

Acciones

ANIP

US00182C1036

Otros idiomas

Filtros